Overview

A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer

Status:
Recruiting
Trial end date:
2025-12-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out how effective and safe glipizide is for lowering blood sugar in people with pancreatic cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Treatments:
Glipizide